NUROFEN IN RECTAL SUPPOSITORIES IN FEBRILE CHILREN
Issue:
1
Year:
2015
The paper gives the main features and advantages of ibuprofen (Nurofen) as rectal suppositories over acetaminophen (Paracetamol) in young children with acute respiratory viral infections accompanied by hyperthermia; Nurofen suppositories provide a more pronounced and prolonged antipyretic effect, abolish fever 1.2 times more promptly, and have a higher safety profile.
Keywords:
acute respiratory viral infections
infants
Nurofen
References:
- Geppe N.A., Ozerskaja I.V. Ibuprofen – mesto v taktike zharoponizhaju schej terapii u detej // Pediatrija. – 2013; 2: 107–11.
- Geppe N.A. Pervaja Mezhdunarodnaja konferentsija po primeneniju ibu-profena v pediatrii // Ros. med. zhurn. – 2002; 18 (162): – 831–5.
- Zaharova I.N., Zaplatnikov A.L., Tvorogova T.M. i dr. Osobennosti vybora zharoponizhajuschih sredstv u detej s allergicheskimi zabolevanijami // Rus. med. zhurn. – 2014; 3: 220–4.
- Zaharova I.N., Tvorogova T.M. Primenenie zharoponizhajuschih preparatov pri lihoradke u detej // Voprosy prakticheskoj pediatrii. – 2013; 8 (1): 63–6.
- Korovina N.A., Zaplatnikov A.L., Zaharova I.N. i dr. Febril'nye sudorogi i ratsional'noe primenenie zharoponizhajuschih lekarstvennyh sredstv u detej // Voprosy sovremennoj pediatrii. – 2004; 3 (5): 112–7.
- Kljuchnikov S.O. Lihoradka i primenenie zharoponizhajuschih preparatov u detej // Pediatrija. – 2012; 91 (4): 121–5.
- Lokshina E.E., Zajtseva O.V., Keshishjan E.S. i dr. Ispol'zovanie zharoponizhajuschih preparatov u detej s ostrymi respiratornymi infektsijami // Pediatrija. – 2010; 89 (2): 113–9.
- Ushkalova E.A. Profil' bezopasnosti anal'getikov-antipiretikov v pediatrii // Rus. med. zhurn. – 2014; 21: 1526–9.
- Shajtor V.M. Zharoponizhajuschie sredstva pri lihoradke u detej // Farmateka. – 2011; 1–11: 28–32.
- Autret-Leca E. A general overview of the use of ibuprofen in paediatrics // Int J Clin Pract Suppl. – 2003; 135: 9–12.
- utret-Leca E., Gibb I., Goulder M. Ibuprofen versus paracetamol in pediatric fever: objective and subjective findings from a randomized blinded study // Curr. Med. Res. Opin. – 2007; 23: 2205–11.
- Brune K., Hinz B., Otterness I. Aspirin and acetaminophen: should they be available over the counter? // Curr. Rheumatol. Rep. – 2009; 11 (1): 36–40.
- Del Rosso J., Kircik L. Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolonepivalate 0.1% cream // J. Drugs Dermatol. – 2014; 13 (7): 77–83.
- Hay A., Costelloe C., Redmond N. Paracetamol plus ibuprofen for the treatment of fever in children: randomised controlled trial // BMJ. – 2008; 337: 729–33.
- Haywood A. Pharmaceutical excipients – where do we begin? // Aust. Prescr. – 2011; 34: 112–4.King J., Davis T., Bailey S. et al. Developing consumer-centered, nonprescription drug labeling a study in acetaminophen // Am. J. Prev. Med. – 2011; 40 (6): 593–8.
- Larrey D., Pageaux G. Genetic predisposition to drug-induced hepatotoxicity // J. Hepatol. – 1997; 26 (Suppl. 2): 12–21
- Lundstrom K. Ibuprofen is more effective than paracetamol in lowering the temperature in febrile children // Ugeskr. Laeger. – 2012; 174 (18): 1214–7.
- Maguire T. Ibuprofen: a model medicine for self-care of common conditions // Int. J. Clin. Pract. Suppl. – 2013; 178: 43–6.
- Martinez-Gimeno A., Garcia-Marcos L. The association between acetaminophen and asthma: should its pediatric use be banned? // Expert Rev. Respir. Med. – 2013; 7 (2): 113–22.
- Mazer M., Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management // J. Med. Toxicol. – 2008; 4 (1): 2–6.
- Rainsford K. Ibuprofen: pharmacology, efficacy and safety // Inflammopharmacology. – 2009; 17 (6): 275–342.
- Pawar S., Kumar A. Issues in the formulation of drugs for oral use children: role of excipients // Paediatr. Drugs. – 2002; 4 (6): 371–9.
- Sauerwein R., Mulder J., Mulder L. et al. Inflammatory mediators in children with protein-energy malnutrition // Am. J. Clin. Nutr. – 1997; 65: 1534–9.
- Savino F., Lupica M., Tarasco V. et al. Fulminant hepatitis after 10 days of acetaminophen treatment at recommended dosage in an infant // Pediatrics. – 2011; 127 (2): 494–7.
- Song B., Veech R., Saenger P. Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics // J. Clin. Endocrinol. Metab. – 1990; 71: 1036–40.
- Squires R.-Jr., Shneider B., Bucuvalas J. et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group // J. Pediatr. – 2006; 148 (5): 652–8.
- Turner M., Duncan J., Shah U. et al. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas // Adv. Drug. Deliv. Rev. – 2014; 73 (89): 101.
- Zhang W., Parentau H., Greenly R. et al. Effect of protein-calorie malnutrition 29. on cytochromes P450 and glutathione S-transferase // Eur. J. Drug. Metab. Pharmacokinet. – 1999; 24: 141–7.
- Shaoul R., Novikov J., Maor I. et al. Silent acetaminophen-induced 30. hepatotoxicity in febrile children: does this entity exist? // Acta Paediatr. – 2004; 93 (5): 618–22.
- O'Shea D., Davis S., Kim R. et al. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity // Clin. Pharmacol. Ther. – 1994; 56: 359–67.NUR